Authors:
CONLON JM
CHARTREL N
LEPRINCE J
SUAUDEAU C
COSTENTIN J
VAUDRY H
Citation: Jm. Conlon et al., A PROENKEPHALIN A-DERIVED PEPTIDE ANALOGOUS TO BOVINE ADRENAL PEPTIDE-E FROM FROG BRAIN - PURIFICATION, SYNTHESIS, AND BEHAVIORAL-EFFECTS, Peptides, 17(8), 1996, pp. 1291-1296
Authors:
VAUGEOIS JM
POUHE D
ZUCCARO F
COSTENTIN J
Citation: Jm. Vaugeois et al., INDIRECT DOPAMINE AGONISTS EFFECTS ON DESPAIR TEST - DISSOCIATION FROM HYPERACTIVITY, Pharmacology, biochemistry and behavior, 54(1), 1996, pp. 235-239
Authors:
THIBAUT F
VAUGEOIS JM
BONNET JJ
COSTENTIN J
Citation: F. Thibaut et al., IN-VIVO STRIATAL BINDING OF THE D-1 ANTAGONIST SCH-23390 IS NOT MODIFIED BY CHANGES IN DOPAMINERGIC TRANSMISSION, Neuropharmacology, 35(3), 1996, pp. 267-272
Citation: At. Corera et al., EFFECT OF LOW CONCENTRATIONS OF K- ON THE NA+-DEPENDENT NEURONAL UPTAKE OF [H-3] DOPAMINE( AND CL), Naunyn-Schmiedeberg's archives of pharmacology, 353(6), 1996, pp. 610-615
Authors:
BOULAY D
DUTERTEBOUCHER D
LEROUXNICOLLET I
NAUDON L
COSTENTIN J
Citation: D. Boulay et al., LOCOMOTOR SENSITIZATION AND DECREASE IN [H-3] MAZINDOL BINDING TO THEDOPAMINE TRANSPORTER IN THE NUCLEUS-ACCUMBENS ARE DELAYED AFTER CHRONIC TREATMENTS BY GBR12783 OR COCAINE, The Journal of pharmacology and experimental therapeutics, 278(1), 1996, pp. 330-337
Authors:
FLORIN S
SUAUDEAU C
MEUNIER JC
COSTENTIN J
Citation: S. Florin et al., NOCICEPTIN STIMULATES LOCOMOTION AND EXPLORATORY-BEHAVIOR IN MICE, European journal of pharmacology, 317(1), 1996, pp. 9-13
Authors:
VAUGEOIS JM
ODIEVRE C
LOISEL L
COSTENTIN J
Citation: Jm. Vaugeois et al., A GENETIC MOUSE MODEL OF HELPLESSNESS SENSITIVE TO IMIPRAMINE, European journal of pharmacology, 316(2-3), 1996, pp. 1-2
Citation: C. Heron et al., COMPLEX IONIC CONTROL OF [H-3] GBR-12783 BINDING TO THE DOPAMINE NEURONAL CARRIER, European journal of pharmacology, 301(1-3), 1996, pp. 195-202
Authors:
RAMASSAMY C
GIRBE F
CHRISTEN Y
COSTENTIN J
Citation: C. Ramassamy et al., PEROXIDATION OF SYNAPTOSOMES ALTERS THE DOPAMINE UPTAKE COMPLEX BUT SPARES THE EXOCYTOTIC RELEASE OF DOPAMINE, Neurodegeneration, 4(2), 1995, pp. 155-160
Authors:
GRIFFON N
SOKOLOFF P
DIAZ J
LEVESQUE D
SAUTEL F
SCHWARTZ JC
SIMON P
COSTENTIN J
GARRIDO F
MANN A
WERMUTH C
Citation: N. Griffon et al., THE DOPAMINE D-3 RECEPTOR AND SCHIZOPHRENIA - PHARMACOLOGICAL, ANATOMICAL AND GENETIC APPROACHES, European neuropsychopharmacology, 5, 1995, pp. 3-9
Citation: P. Simon et al., NON-AMPHETAMINIC MECHANISM OF STIMULANT LOCOMOTOR EFFECT OF MODAFINILIN MICE, European neuropsychopharmacology, 5(4), 1995, pp. 509-514
Authors:
NAUDON L
LEROUXNICOLLET I
RAISMANVOZARI R
BOTTOM D
COSTENTIN J
Citation: L. Naudon et al., TIME-COURSE OF MODIFICATIONS ELICITED BY RESERPINE ON THE DENSITY ANDMESSENGER-RNA SYNTHESIS OF THE VESICULAR MONOAMINE TRANSPORTER, AND ON THE DENSITY OF THE MEMBRANE DOPAMINE UPTAKE COMPLEX, Synapse, 21(1), 1995, pp. 29-36
Citation: C. Suaudeau et J. Costentin, ANALGESIC EFFECT OF THE DIRECT D-2 DOPAMINE-RECEPTOR AGONIST RU-24926AND CROSS-TOLERANCE WITH MORPHINE, Fundamental and clinical pharmacology, 9(2), 1995, pp. 147-152
Authors:
GRIFFON N
DIAZ J
LEVESQUE D
SAUTEL F
SCHWARTZ JC
SOKOLOFF P
SIMON P
COSTENTIN J
GARRIDO F
MANN A
WERMUTH C
Citation: N. Griffon et al., LOCALIZATION, REGULATION, AND ROLE OF THE DOPAMINE D-3 RECEPTOR ARE DISTINCT FROM THOSE OF THE D-2 RECEPTOR, Clinical neuropharmacology, 18, 1995, pp. 130-142
Citation: C. Suaudeau et al., RAPID AND LONG-LASTING REDUCTION OF THE HYPOTHERMIC EFFECT OF A D2 DOPAMINE AGONIST AFTER AN INTRACEREBROVENTRICULAR INJECTION OF 6-HYDROXYDOPAMINE, Neuropharmacology, 34(1), 1995, pp. 101-105
Authors:
REFAHILYAMANI F
SAADOUNI S
COSTENTIN J
BONNET JJ
Citation: F. Refahilyamani et al., INTERACTION OF 2 SULFHYDRYL-REAGENTS WITH A CATION RECOGNITION SITE ON THE NEURONAL DOPAMINE CARRIER EVIDENCES SMALL DIFFERENCES BETWEEN [H-3] GBR-12783 AND [H-3] COCAINE BINDING-SITES, Naunyn-Schmiedeberg's archives of pharmacology, 351(2), 1995, pp. 136-145
Authors:
MEUNIER JC
MOLLEREAU C
TOLL L
SUAUDEAU C
MOISAND C
ALVINERIE P
BUTOUR JL
GUILLEMOT JC
FERRARA P
MONSARRAT B
MAZARGUIL H
VASSART G
PARMENTIER M
COSTENTIN J
Citation: Jc. Meunier et al., ISOLATION AND STRUCTURE OF THE ENDOGENOUS AGONIST OF OPIOID RECEPTOR-LIKE ORL(1) RECEPTOR, Nature, 377(6549), 1995, pp. 532-535
Authors:
SAUTEL F
GRIFFON N
SOKOLOFF P
SCHWARTZ JC
LAUNAY C
SIMON P
COSTENTIN J
SCHOENFELDER A
GARRIDO F
MANN A
WERMUTH CG
Citation: F. Sautel et al., NAFADOTRIDE, A POTENT PREFERENTIAL DOPAMINE D-3 RECEPTOR ANTAGONIST, ACTIVATES LOCOMOTION IN RODENTS, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1239-1246
Citation: B. Naudin et al., ACUTE L-DOPA PRETREATMENT POTENTIATES 6-HYDROXYDOPAMINE-INDUCED TOXICEFFECTS ON NIGRO-STRIATAL DOPAMINE NEURONS IN MICE, Brain research, 701(1-2), 1995, pp. 151-157
Citation: P. Simon et al., THE STIMULANT EFFECT OF MODAFINIL ON WAKEFULNESS IS NOT ASSOCIATED WITH AN INCREASE IN ANXIETY IN MICE - A COMPARISON WITH DEXAMPHETAMINE, Psychopharmacology, 114(4), 1994, pp. 597-600
Citation: R. Khalloukbousselmame et J. Costentin, LOCOMOTOR AND ANALGESIC EFFECTS OF MORPHINE AND ACETORPHAN IN RATS CHRONICALLY TREATED WITH MORPHINE OR THIORPHAN, European neuropsychopharmacology, 4(2), 1994, pp. 137-143
Authors:
BILLAUD G
MENARD JF
MARCELLIN N
KAMENKA JM
COSTENTIN J
BONNET JJ
Citation: G. Billaud et al., THERMODYNAMICS OF THE BINDING OF BTCP-(GK-13) AND RELATED DERIVATIVESON THE DOPAMINE NEURONAL CARRIER, European journal of pharmacology. Molecular pharmacology section, 268(3), 1994, pp. 357-363
Authors:
SAADOUNI S
REFAHILYAMANI F
COSTENTIN J
BONNET JJ
Citation: S. Saadouni et al., COCAINE AND GBR-12783 RECOGNIZE NONIDENTICAL, OVERLAPPING BINDING DOMAINS ON THE DOPAMINE NEURONAL CARRIER, European journal of pharmacology. Molecular pharmacology section, 268(2), 1994, pp. 187-197